Skip to main content

Table 1 Patient characteristics of patient Cohort I, II and III

From: Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH

 

Cohort I

Cohort II

Cohort III

Cycles (n)

1247

1514

632

Embryos (n)

4.9 ± 4.3

4.0 ± 3.4

4.1 ± 3.5

Age (years)

37.8 ± 6.7

39.5 ± 5.0

39.5 ± 4.9

FSH (mIU/mL)

17.3 ± 19.1

15.4 ± 14.8

15.8 ± 16.2

AMH (ng/mL)

1.1 ± 1.9

1.1 ± 1.9

1.1 ± 1.9

Pregnancies

 n

346

246

106

 %

27.8

16.2

16.8

Live births

 n

264

178

73

 %

21.2

11.8

11.6

Miscarriages

 n

82

68

33

 %

23.7

27.6

31.3